73 results on '"Asakuma, J."'
Search Results
2. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma
- Author
-
Kuroda, K., primary, Asakuma, J., additional, Asano, T., additional, Horiguchi, A., additional, Isono, M., additional, Tsujita, Y., additional, Sato, A., additional, Seguchi, K., additional, and Ito, K., additional
- Published
- 2014
- Full Text
- View/download PDF
3. 574 Detection of factors affecting early bladder recurrence after nephroureterectomy in patients with N0M0 upper urinary tract urothelial carcinoma
- Author
-
Kuroda, K., primary, Asakuma, J., additional, Horiguchi, A., additional, Tasaki, S., additional, Sato, A., additional, Seguchi, K., additional, Ito, K., additional, and Asano, T., additional
- Published
- 2013
- Full Text
- View/download PDF
4. 827 Novel anticancer effect of proteasome inhibitor on prostate cancer cells targeting prostate-specific membrane antigen and androgen receptor
- Author
-
Kuroda, K., primary, Horiguchi, A., additional, Asano, T., additional, Tasaki, S., additional, Asakuma, J., additional, Sato, A., additional, Seguchi, K., additional, and Ito, K., additional
- Published
- 2013
- Full Text
- View/download PDF
5. 280 HIV protease inhibitor ritonavir increases heat sensitivity of renal cancer cells by inhibiting heat-induced NF-kappaB activation
- Author
-
Sato, A., primary, Asano, T., additional, Asakuma, J., additional, Horiguchi, A., additional, Ito, K., additional, and Sumitomo, M., additional
- Published
- 2010
- Full Text
- View/download PDF
6. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma
- Author
-
Horiguchi, A, primary, Asano, T, additional, Kuroda, K, additional, Sato, A, additional, Asakuma, J, additional, Ito, K, additional, Hayakawa, M, additional, and Sumitomo, M, additional
- Published
- 2010
- Full Text
- View/download PDF
7. Clinical Impact of the Presence of the Worst Nucleolar Grade in Renal Cell Carcinoma Specimens
- Author
-
Ito, K., primary, Yoshii, H., additional, Asakuma, J., additional, Sato, A., additional, Horiguchi, A., additional, Sumitomo, M., additional, Hayakawa, M., additional, and Asano, T., additional
- Published
- 2009
- Full Text
- View/download PDF
8. The diagnostic value of pre-biopsy magnetic resonance imaging for precise detection of clinically localized prostate cancer compared to post-biopsy setting
- Author
-
Takahashi, M., Horiguchi, A., Tasaki, S., Kuroda, K., Akinori Sato, Asakuma, J., Seguchi, K., Hayakawa, M., Ito, K., Asano, T., Tamura, C., and Shinmoto, H.
9. High frequency of concomitant squamous metaplasia in bulbar urethral stricture and its association with reconstructive delay and urethral rest.
- Author
-
Hirano Y, Horiguchi A, Shinchi M, Ojima K, Kimura F, Takahashi E, Asakuma J, Uemura S, Tsuda H, Miyai K, and Ito K
- Subjects
- Humans, Male, Retrospective Studies, Middle Aged, Aged, Adult, Time-to-Treatment, Urethral Stricture epidemiology, Urethral Stricture pathology, Urethral Stricture surgery, Metaplasia, Urethra pathology, Urologic Surgical Procedures, Male methods
- Abstract
Purpose: To determine the prevalence of concomitant squamous metaplasia (SM), the initial histological change from normal urethra to urethral stricture, in bulbar urethral strictures and to investigate the associated clinical factors., Methods: A retrospective review was conducted on 165 male patients with bulbar urethral strictures who underwent excision and primary anastomosis (EPA) between 2010 and 2020, for whom complete clinical data and excised urethral specimens were available. An experienced pathologist histologically evaluated concomitant SM in paraffin sections of the proximal end of the excised urethra blinded to the clinical data. Disease duration was calculated as the period from the initial diagnosis of urethral stricture to the date of EPA. The association between concomitant SM and clinical background was investigated., Results: SM was identified in 86 (52.1%) patients. The median disease duration in patients with SM (38 months) was significantly longer than that in patients without SM (9 months, p < 0.0001). In multivariate analysis, the longer disease duration, non-traumatic stricture etiology, and failure to maintain urethral rest with urinary diversion via a suprapubic tube for more than 90 days were independent factors predicting concomitant SM. No significant difference was observed in success rates of EPA between patients with SM (93.2%) and those without SM (97.5%, p = 0.18)., Conclusions: Reconstructive urologists need to be aware that concomitant SM is frequent in patients with bulbar urethral stricture, especially in those with long disease duration and those who were voiding volitionally during the period of urethral rest., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
10. Immune checkpoint inhibitor-related myositis and myocarditis with multiple myositis-specific/-associated antibodies.
- Author
-
Isa M, Hongo Y, Sakamoto N, Yamazaki K, Takazaki H, Asakuma J, Ikewaki K, and Suzuki K
- Subjects
- Humans, Immune Checkpoint Inhibitors, Myocarditis chemically induced, Myocarditis diagnostic imaging, Myositis chemically induced, Myositis diagnostic imaging, Antineoplastic Agents, Immunological adverse effects, Polymyositis
- Published
- 2023
- Full Text
- View/download PDF
11. Efficacy of urethral reconstruction for urethral stricture associated with hypospadias surgery in adults.
- Author
-
Horiguchi A, Asanuma H, Shinchi M, Tabei T, Ojima K, Hirano Y, Takahashi E, Asakuma J, Kimura F, Ito K, and Azuma R
- Subjects
- Male, Adult, Humans, Aged, Urologic Surgical Procedures, Male adverse effects, Urologic Surgical Procedures, Male methods, Retrospective Studies, Quality of Life, Treatment Outcome, Urethra surgery, Urethral Stricture etiology, Urethral Stricture surgery, Hypospadias surgery
- Abstract
Objectives: We report our experience with urethral reconstruction for hypospadias surgery-related urethral stricture in terms of surgical and patient-reported outcomes., Methods: Twenty-nine adult males who underwent urethral reconstruction for hypospadias surgery-related urethral stricture between August 2008 and January 2022 were retrospectively reviewed. Uroflowmetry and patient-reported outcomes were evaluated at 3, 6, and 12 months, and annually thereafter. Surgical success was defined as the absence of additional procedures. Patients were asked to rate their satisfaction with urethral reconstruction as "very satisfied", "satisfied", "unsatisfied", or "very unsatisfied"., Results: The median patient age at referral was 43 years. The median number of previously performed hypospadias surgeries was three, and 18 patients (62.8%) had been treated with repeated transurethral procedures. The median stricture length was 54 mm (interquartile range 36-81). Performed urethral reconstruction included staged urethroplasty in 22 (75.9%), one-stage onlay augmentation in 3 (10.2%), and perineal urethrostomy in 4 (13.8%) cases. Urethral reconstruction was successful in 26 patients (89.7%) over a median postoperative period of 31 months. Patient-reported outcomes were assessed in 25 (86.2%) patients. The mean maximum flow rate, international prostate symptom score total score, international prostate symptom score quality of life score, and EuroQol-5 dimensions index significantly improved postoperatively. Twenty-three patients (92%) were "very satisfied" or "satisfied" with the outcome of their urethral reconstruction., Conclusions: Urethral reconstruction is a highly successful and patient-satisfying treatment for hypospadias surgery-related urethral stricture in adult patients. Perineal urethrostomy is a reasonable alternative for elderly patients and for patients with complicated hypospadias surgery-related urethral strictures., (© 2022 The Japanese Urological Association.)
- Published
- 2022
- Full Text
- View/download PDF
12. [A Case of Massive Prostate Abscess Treated by Transperineal Drainage].
- Author
-
Yokoyama T, Kitamura Y, Hatanaka M, Arai Y, Tujita Y, Tasaki S, Kuroda K, Asakuma J, Horiguchi A, and Ito K
- Subjects
- Aged, 80 and over, Drainage methods, Humans, Male, Minocycline, Prostate, Abscess diagnostic imaging, Abscess surgery, Prostatic Diseases diagnostic imaging, Prostatic Diseases surgery
- Abstract
The patient was an 81-year-old man who visited a clinic for fever and lower abdominal pain. He was subsequently diagnosed with prostatitis based on computed tomography (CT) findings that showed swelling of the prostate. Despite treatment with antibacterial therapy, his symptoms did not improve significantly. Since the patient also had myelodysplastic syndrome, he was transferred to our hospital and subsequently diagnosed with prostate abscess based on findings on magnetic resonance imaging (MRI). The abscess had spread widely from the dorsal side of the trigone of the bladder to anterior wall of the rectum. Transperineal drainage was performed to preserve the urethral mucosa of the prostatic urethra. Considering the shape of the abscess cavity, one pigtail catheter was placed in the prostate and another was placed transperineally on the dorsal side of the trigone of the bladder. Cystostomy was performed at the same time. Culture of the abscess revealed the presence of Staphylococcus aureus. As there was little exudate from the abscess 9 days after drainage, the pigtail catheter on the dorsal side of the trigone of the bladder was removed following an injection of minocycline into the abscess. CT showed shrinkage of the abscess 4 days later, and the remaining intraprostatic pigtail catheter was removed after an injection of minocycline. The cystostomy pigtail catheter was subsequently removed since the patient was able to urinate smoothly after clamping. MRI confirmed the disappearance of the abscess cavity 2 months later.
- Published
- 2022
- Full Text
- View/download PDF
13. Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival.
- Author
-
Kawamura K, Miyai K, Asakuma J, Sato K, Matsukuma S, Tsuda H, and Ito K
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma mortality, Carcinoma surgery, Chemotherapy, Adjuvant, Female, Humans, Kidney Neoplasms mortality, Kidney Neoplasms surgery, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Neoplasm Staging, Nephrectomy, Progression-Free Survival, Risk Assessment, Risk Factors, Time Factors, Ureteral Neoplasms mortality, Ureteral Neoplasms surgery, Urothelium surgery, Carcinoma secondary, Cell Movement, Kidney Neoplasms pathology, Ureteral Neoplasms pathology, Urothelium pathology
- Abstract
Tumor budding, defined as a single cancer cell or clusters of fewer than five cancer cells observed at the tumor invasion front, has been reported to be associated with poor prognosis in various types of cancers. However, limited information regarding the pathological and prognostic significance of tumor budding in upper urinary tract urothelial carcinoma (UUTUC) is available. We investigated 135 consecutive patients with newly diagnosed invasive UUTUCs (73 with renal pelvic cancers and 62 with ureteral cancers) treated with nephroureterectomy or partial ureterectomy between 1999 and 2018 in our hospital. Under a × 200 magnification, tumors with 10 or more budding foci were defined as "high tumor budding". The median follow-up period was 53.6 months. Among the 135 patients, 41 (30%; 16 with renal pelvic cancers and 25 with ureteral cancers) showed high tumor budding. High tumor budding was related to adjuvant chemotherapy status, higher pathological T stage, lymphovascular invasion, lymph node metastasis, tumor location, concomitant variant histology, and non-papillary gross finding. The multivariate Cox analysis revealed that LVI and high tumor budding were independent predictors for extraurothelial recurrence (P = 0.039 and 0.014, hazard ratio = 2.50 and 2.88, respectively), and high tumor budding was an independent predictor for overall survival (P = 0.024, hazard ratio = 2.33). Tumor budding can be easily introduced in clinical practice with no need for immunohistochemical analysis, may be an important clinicopathological factor of UUTUC, and is suggested to be useful as a novel predictive prognostic factor of patients with invasive UUTUC., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
14. Preoperative risk stratification using plasma fibrinogen levels can predict lymphovascular invasion and poor prognosis in patients with upper urinary tract urothelial carcinoma.
- Author
-
Kuroda K, Tasaki S, Asakuma J, Horiguchi A, and Ito K
- Abstract
It has been previously indicated that preoperative plasma fibrinogen levels can correlate with cancer progression and be used as a useful predictor of lymph node metastasis or its premetastatic status such as lymphovascular invasion (LVI). In the present study, how preoperative plasma fibrinogen levels, considered in conjunction with other clinicopathological factors, can predict the presence of LVI and prognosisin patients with upper urinary tract urothelial carcinoma (UTUC) was examined. Medical records of 145 patients with UTUC who underwent radical nephroureterectomy (RNU) were retrospectively reviewed. The current study evaluated systemic inflammatory response markers including levels of plasma fibrinogen and other clinicopathological factors in orderto determine independent predictors of LVI and prognosis. The Cox proportional hazards model indicated that positive surgical margins and LVI were independent factors for poor cancer-specific survival (CSS) rates and extraurothelial recurrence-free survival (ERFS) rates. In addition, positive cytology, the presence of hydronephrosis and plasma fibrinogen levels were significant preoperative predictors of LVI. Furthermore, patients exhibiting two or more of higher fibrinogen levels (≥400 mg/dl), positive urine cytology and the presence of hydronephrosis were indicated to exhibit worse CSS or ERFS rates compared with patients exhibiting only one of the aforementioned factors or those with none of the three aforementioned factors in the multivariate analysis of the Cox proportional hazards model. In conclusion, hyperfibrinogenemia can be an independent predictor of the presence of LVI, and stratifying preoperative risk using fibrinogen levels, urine cytology and hydronephrosis can serve as the basis for selecting candidates for additional therapy before and/or after RNU in patients with UTUC., Competing Interests: The authors declare that they have no competing interests., (Copyright: © Kuroda et al.)
- Published
- 2021
- Full Text
- View/download PDF
15. A rare case of isolated splenic sarcoidosis: A case report and literature review.
- Author
-
Kobayashi K, Einama T, Fujinuma I, Tsunenari T, Miyata Y, Iwasaki T, Asakuma J, Soga S, Shinmoto H, Tsujimoto H, Hase K, Ueno H, and Kishi Y
- Abstract
Sarcoidosis is a multisystemic granulomatous disease. It is rarely isolated in the spleen. The present report describes a case of isolated splenic sarcoidosis that was diagnosed histologically following laparoscopic splenectomy. A 76-year-old woman, who underwent radical nephroureterectomy 7 years earlier for left renal pelvic cancer and mastectomy 6 years earlier for left breast cancer in another facility, was referred to our hospital for assessment of splenic tumors that were identified during a follow-up examination. The computed tomography scans revealed multiple nodules in the spleen, which had increased in size over 2 years. Positron emission tomography revealed accumulation of [18F]-fluorodeoxyglucose in the spleen. Laparoscopic splenectomy was performed and the diagnosis of sarcoidosis was confirmed histologically. A review of previous reports and the present case suggested that diagnosis of splenic sarcoidosis should be considered when the CT scans show multinodular splenic tumors, and sarcoidosis might be associated with malignant tumors., (Copyright: © Kobayashi et al.)
- Published
- 2021
- Full Text
- View/download PDF
16. [CLINICAL ANALYSIS OF 95 CASES OF PERCUTANEOUS CYSTOSTOMY].
- Author
-
Takekawa K, Kawaguchi M, Kuroda K, Hirano Y, Hamamoto K, Arai Y, Hatanaka M, Kitamura Y, Kawamura K, Ojima K, Tachi K, Tasaki S, Asakuma J, Horiguchi A, and Ito K
- Subjects
- Cystostomy methods, Cystotomy, Female, Hemorrhage etiology, Humans, Male, Prostatic Hyperplasia, Urethral Stricture
- Abstract
(Introduction) Percutaneous cystostomy is a standard urological procedure; however, very few reports have focused on the many cases of this procedure performed in Japan. We analyzed the background of the procedure and its approach as well as the incidence of its complications at our institution. (Material and methods) We examined 95 patients who underwent percutaneous cystostomy between April 2010 and March 2019. A comparative analysis was conducted for each type of procedure performed. Furthermore, cases that experienced accidental catheter extraction before the first catheter replacement were analyzed, and the three patient groups were compared based on the type of procedure performed and cases that needed another operation. (Result) The indications for cystostomy were urethral stricture (56.3%), neuropathic bladder (13.5%), and prostatic hyperplasia (11.5%). The complications included hemorrhage, peritoneal injury, urinary tract infection, and catheter damage caused by a puncture needle. The overall complication rate was 10.5%. Based on type of the procedure performed, the incidence of hemorrhage was found to be as high as 25% in patients who underwent the procedure using a cannula puncture needle. Accidental catheter extraction before the first catheter replacement occurred most frequently in patients treated with Seldinger technique (17.0%). The rate of complications including accidental catheter extraction ranged from 25.0% to 25.4% among the three groups. (Conclusion) We prefer the Seldinger technique for the first placement of the cystostomy catheter because of its low rate of hemorrhage, but a cannula puncture needle may also be used by using exploratory puncture if vascular damage and accidental catheter extraction are avoided.
- Published
- 2021
- Full Text
- View/download PDF
17. Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer.
- Author
-
Kuroda K, Tasaki S, Sato A, Asakuma J, Horiguchi A, and Ito K
- Abstract
A single immediate instillation of chemotherapy following transurethral resection of bladder tumor (TURBT) is effective in preventing intravesical recurrence (IVR) in patients with non-muscle-invasive urothelial bladder carcinoma (NMIBC). However, continuous saline bladder irrigation (CSBI) is also performed with a single instillation of chemotherapy (SIC), but its inhibitory effect on IVR remains unclear. In the present study, the effect of CSBI with concomitant SIC following TUR on IVR was evaluated in patients with NMIBC. A retrospective review of 253 patients who underwent TURBT and were clinically and histologically diagnosed with NMIBC at National Defense Medical College Hospital was performed. Doxorubicin (DXR) was administered to all patients. Methods of DXR administration included a single instillation of DXR (60 mg in 30-40 ml saline) in 34 patients (group A), continuous irrigation of the bladder with saline including DXR (80 mg in 1 liter saline) in 40 patients (group B) and overnight CSBI after a single instillation of DXR in 179 patients (group C). The difference in IVR-free survival rates was compared after adjusting for significant differences in several covariates between the groups by nearest-neighbor propensity score matching. Prior to propensity score matching, it was identified that time to IVR was significantly longer in group A than in groups B and C; however, it was observed that several factors significantly differed among the three groups. By using nearest neighbor matching, 18 pairs were matched between groups A and B and 33 pairs between the groups A and C. No significant difference was identified in any covariates between these two matched group pairsTime to IVR was significantly longer in the matched group A than in the matched groups B and C (P=0.0255 and P=0.0023, respectively). In conclusion, SIC alone could provide a higher IVR-free survival rate than CSBI with DXR or CSBI with SIC., (Copyright: © Kuroda et al.)
- Published
- 2020
- Full Text
- View/download PDF
18. Chronic kidney disease and positive surgical margins as prognosticators for upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy.
- Author
-
Kuroda K, Asakuma J, Horiguchi A, Kawaguchi M, Shinchi M, Masunaga A, Tasaki S, Sato A, and Ito K
- Abstract
Chronic kidney disease (CKD) is a common condition among elderly patients and has been reported to be a biomarker for the presence of malignant disease. In addition, unfavorable outcomes for patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy can be due to independent clinical factors. Therefore, the present study analyzed the clinicopathological data of patients with UTUC, who underwent radical nephroureterectomy at our institution, to clarify whether preoperative CKD and other factors are independent predictors of the shorter disease-specific and/or recurrence-free survival time of these patients. A retrospective review of 187 patients who underwent radical nephroureterectomy was conducted, and patients were followed for at least 3 months postoperatively. The clinicopathological factors that are thought to have potentially significant roles in the progression and metastasis of malignant tumors and for disease-specific and recurrence-free survival were evaluated. Positive surgical margins and an estimation of the glomerular filtration rate (eGFR) of <60 were independent factors for the shorter disease-specific survival time in multivariate analysis with Cox's proportional hazards model [hazard ratio (HR), 2.401: 95% confidence interval (CI), 1.044-5.255; and HR, 2.371: 95% CI, 1.024-5.898, respectively]. Another multivariate analysis also revealed that positive surgical margins (HR, 4.477; 95% CI, 2.042-9.469), and preoperative eGFR <60 (HR, 2.362; 95% CI, 1.067-5.592) were independent factors for the worse recurrence-free survival rate in all patients. Patients with UTUC who had eGFR <60 as well as positive surgical margins had significantly shorter time to disease-specific mortality and extraurothelial recurrence. The present study demonstrated that patients with UTUC undergoing radical nephroureterectomy who have CKD as well as positive surgical margins should be carefully followed up postoperatively.
- Published
- 2019
- Full Text
- View/download PDF
19. [A CASE OF EMPHYSEMATOUS PYELONEPHRITIS WHO PRESENTED THE PRESERVATION OF THE IPSILATERAL KIDNEY FOLLOWING OPEN DRAINAGE].
- Author
-
Kawaguchi M, Kuroda K, Yagi K, Kitamura Y, Kawamura K, Ojima K, Asakuma J, Asano T, Shinmoto H, and Ito K
- Subjects
- Female, Humans, Middle Aged, Treatment Outcome, Drainage methods, Emphysema surgery, Pyelonephritis surgery
- Abstract
We report a case of a 53-year-old woman with emphysematous pyelonephritis who presented the preservation of the ipsilateral kidney following open drainage. She was transferred to our hospital with chief complaints of right back pain and high fever. On diagnosis, diabetes mellitus and a stone in the right ureter were confirmed, and she was followed up at a local clinic. Computed tomography revealed the presence of gas in the right renal pelvis, and the stone led to right hydronephrosis. Additionally, her hemoglobin A1c level was 11.3%. Hence, we diagnosed the patient with emphysematous pyelonephritis. Although right percutaneous nephrostomy was performed immediately after her admission, the gas in the right renal pelvis extended to the renal parenchyma one day later. Therefore, we performed open drainage of the right kidney to control severe inflammation. The gas disappeared after the procedure, and her systemic status gradually improved. We hypothesize that emphysematous pyelonephritis is treated with open drainage instead of nephrectomy while preserving the ipsilateral kidney.
- Published
- 2019
- Full Text
- View/download PDF
20. Impact of body mass index on clinicopathological outcomes in patients with renal cell carcinoma without anorexia-cachexia syndrome.
- Author
-
Watanabe D, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Ito K, and Asano T
- Abstract
Although obesity defined by a high body mass index (BMI) is generally associated with increased risk of renal cell carcinoma (RCC), low BMI has paradoxically been associated with increased tumor aggressiveness and poor prognosis. As anorexia-cachexia syndrome (ACS) is associated with decreased BMI and is frequently observed in patients with advanced RCC, the present study investigated the association of BMI with tumor aggressiveness and prognosis in RCC in relation to ACS. The association of BMI with clinicopathological parameters was analyzed in 503 consecutive patients who underwent surgery for RCC. Kaplan-Meier curves and rates of overall survival (OS) stratified by BMI were also compared in relation to the presence or absence of ACS, defined as the presence of anorexia or malaise, and/or weight loss and/or hypoalbuminemia. Low BMI was significantly associated with high-grade tumors (P=0.0027) and the presence of distant metastasis (P=0.0025), and patients with a lower BMI had significantly shorter OS than those with a higher BMI (P=0.0441). Patients with ACS had a significantly lower BMI (mean, 21.5 kg/m
2 ) than those without ACS (mean, 23.5 kg/m2 ; P<0.0001) and had significantly shorter OS than those without ACS (P<0.0001). On multivariate analysis, ACS was an independent predictor of short OS [P=0.0089; hazard ratio (HR), 2.21; 95% confidence interval (CI), 1.22-3.92] and short cancer-specific survival (P=0.0308; HR, 2.03; 95% CI, 1.07-3.78); however, BMI was not (P=0.5440 and P=0.6804, respectively). In the 413 patients without ACS at initial presentation, BMI was not associated with any clinicopathological parameters or OS (log-rank, P=0.4591). BMI itself was not a predictor of survival in patients without ACS, and the association between low BMI and increased tumor aggressiveness and poor prognosis could be due to ACS.- Published
- 2018
- Full Text
- View/download PDF
21. Clinical implication of ectopic liver lipid accumulation in renal cell carcinoma patients without visceral obesity.
- Author
-
Watanabe D, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Ito K, Asano T, and Shinmoto H
- Subjects
- Adult, Aged, Aged, 80 and over, Body Mass Index, Carcinoma, Renal Cell diagnostic imaging, Carcinoma, Renal Cell pathology, Fatty Liver complications, Fatty Liver diagnostic imaging, Female, Humans, Kaplan-Meier Estimate, Kidney Neoplasms diagnostic imaging, Kidney Neoplasms pathology, Male, Middle Aged, Obesity, Abdominal diagnostic imaging, Tomography, X-Ray Computed, Carcinoma, Renal Cell complications, Kidney Neoplasms complications, Lipid Metabolism, Liver metabolism, Obesity, Abdominal complications
- Abstract
Fatty liver has emerged as a prognostic marker of cancer, so we investigated the impact of ectopic lipid accumulation in liver on the clinical outcome for patients with renal cell carcinoma (RCC). The records of 230 consecutive patients who had undergone surgery for RCC were reviewed, and liver lipid accumulation was estimated from the attenuation in unenhanced preoperative CT images. The median liver CT values of patients with G3 tumors was lower than that of patients with G1-2 tumors (P = 0.0116), that of patients with pT3-4 tumors was lower than that of patients with pT1-2 tumors (P = 0.0336), and that of patients with visceral obesity defined as a visceral fat area ≥ 100 cm
2 was lower than that of patients without visceral obesity (P < 0.0001). In patients without visceral obesity the median liver CT values of patients with pT3-4 tumors was lower than that of patients with pT1-2 tumors (P = 0.0401), that of patients with metastasis was lower than that of patients without metastasis (P = 0.026), and fatty liver was associated with shorter overall survival (P = 0.0009). Ectopic lipid accumulation in liver thus seems to be a predictor of aggressive forms of RCC.- Published
- 2017
- Full Text
- View/download PDF
22. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.
- Author
-
Ito K, Soga S, Seguchi K, Shinchi Y, Masunaga A, Tasaki S, Kuroda K, Sato A, Asakuma J, Horiguchi A, Shinmoto H, Kaji T, and Asano T
- Abstract
Partial nephrectomy is the treatment of choice for small renal cell carcinoma (RCC) from the perspective of cancer management and renal function. However, when patients with RCC are of advanced age, exhibit severe comorbidities, including cardiovascular and pulmonary diseases, or have hereditary RCC, ablative therapies, including radiofrequency ablation (RFA) and cryoablation are useful treatment options. In the present study, the clinical outcomes of percutaneous RFA for treating small RCC were evaluated. Between December 2005 and March 2015, 40 patients (41 renal tumors in total) underwent RFA and a total of 50 sessions of RFA were performed. The average tumor size was 2.5 cm. A total of 18 tumors were exophytic and 23 were parenchymal. Of the 41 tumors, 85.4% were completely ablated by initial RFA and the rate of complete ablation following reablation for residual viable lesions was 95.1%. Local recurrence-free survival following complete ablation was 84.2% at 3 years. A patient with a 4.7 cm RCC tumor rapidly progressed following four RFA treatments until complete ablation was achieved. The metastasis-free survival rate following initial RFA was 95.7% at 3 years. The RCC-specific survival was 100% (mean follow-up, 38 months). Adverse events occurred in five sessions (10%); however, only 1 patient with arteriovenous fistula required intervention (transarterial embolization). The mean hospital stay following RFA was 3.2 days. The mean decrease in estimated glomerular filtration rate following RFA was 2.7%. The results of the present study indicate that percutaneous RFA was an effective treatment for small RCCs with respect to management of cancer, minimal invasiveness and minimal loss of renal function, particularly in patients for whom surgery would be a high risk and those at increased risk of deterioration of renal function.
- Published
- 2017
- Full Text
- View/download PDF
23. Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.
- Author
-
Sawazaki H, Ito K, Asano T, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi K, and Asano T
- Subjects
- Aged, Female, Humans, Immunohistochemistry, Japan epidemiology, Kidney pathology, Male, Middle Aged, Neoplasm Staging, Nucleophosmin, Prognosis, Recurrence, Retrospective Studies, Risk Assessment methods, Survival Rate, Ureter pathology, Carcinoma diagnosis, Carcinoma metabolism, Carcinoma mortality, Carcinoma pathology, Kidney Neoplasms diagnosis, Kidney Neoplasms metabolism, Kidney Neoplasms mortality, Kidney Neoplasms pathology, Nephroureterectomy methods, Nephroureterectomy statistics & numerical data, Nuclear Proteins metabolism, Ureteral Neoplasms diagnosis, Ureteral Neoplasms metabolism, Ureteral Neoplasms mortality, Ureteral Neoplasms pathology, Urothelium pathology
- Abstract
Purpose: We aimed to evaluate whether increased nucleophosmin expression predicts recurrence and survival in upper tract urothelial carcinoma (UTUC)., Methods: Specimens from 101 patients with N0M0 UTUC undergoing radical nephroureterectomy were evaluated. Nucleophosmin expression was determined immunohistochemically and categorized into two groups according to nucleophosmin staining intensity. The association between nucleophosmin expression and various clinicopathological factors including Ki-67 expression was analyzed. Multivariate analyses were performed to identify the independent predictors of extraurothelial recurrence and cancer-specific survival., Results: High nucleophosmin expression was significantly correlated with tumor location, pT ≥3, lymphovascular invasion, lymph node metastasis, and high Ki-67 expression. Patients whose tumors demonstrated high nucleophosmin expression had a significantly higher rate of extraurothelial recurrence and a lower survival rate than those with low nucleophosmin expression. Multivariate analysis showed that pT ≥3, lymph node metastasis, high nucleophosmin expression, and high Ki-67 expression were independent predictors of extraurothelial recurrence. When patients were stratified into three groups according to the number of risk factors, the 2-year extraurothelial recurrence-free survival rates were 92.9% in patients with 0 or 1 risk factor, 76.5% in patients with 2 risk factors, and 9.1% in patients with 3 or 4 risk factors. Regarding cancer-specific survival, lymphovascular invasion and high nucleophosmin expression were independent predictors., Conclusions: Increased nucleophosmin expression was a strong predictor of extraurothelial recurrence and cancer-specific survival in patients with N0M0 UTUC undergoing radical nephroureterectomy. Our risk stratification models integrating nucleophosmin expression may provide valuable information on disease recurrence and prognosis.
- Published
- 2017
- Full Text
- View/download PDF
24. [A CASE OF METASTATIC BLADDER UROTHELIAL CARCINOMA WHOSE DISEASE WAS CONTROLLED FOR A RELATIVE LONG PERIOD BY MULTIDISCIPLINARY TREATMENT INCLUDING RADIATION TO A LUNG METASTASIS AND MULTIPLE COURSES OF CHEMOTHERAPY].
- Author
-
Hamada S, Ito K, Kanbara T, Tsujita Y, Yoshii H, Tasaki S, Asakuma J, Horiguchi A, and Asano T
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols administration & dosage, BCG Vaccine administration & dosage, Carcinoma pathology, Cisplatin administration & dosage, Combined Modality Therapy, Doxorubicin administration & dosage, Fatal Outcome, Female, Humans, Infusions, Intra-Arterial, Kidney Neoplasms secondary, Kidney Neoplasms therapy, Kidney Pelvis, Liver Neoplasms secondary, Liver Neoplasms therapy, Methotrexate administration & dosage, Neoplasm Invasiveness, Organ Sparing Treatments, Time Factors, Ureteral Neoplasms secondary, Ureteral Neoplasms therapy, Urinary Bladder Neoplasms pathology, Vinblastine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma therapy, Chemoradiotherapy methods, Lung Neoplasms secondary, Lung Neoplasms therapy, Urinary Bladder surgery, Urinary Bladder Neoplasms therapy
- Abstract
A 67-year-old woman complained of urinary frequency and gross hematuria. She was referred to our hospital with the diagnosis of bladder tumor. Transurethral resection of the bladder tumor (TURBT) was performed and pathological diagnosis was urothelial carcinoma (G2>G3) with muscular invasion. Because she hoped bladder preservation therapy, she received two courses of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) therapy, one course of arterial infusion chemotherapy, and chemoradiotherapy with cisplatin. After those therapies she underwent 4 times of TURBT and two courses intravesical BCG therapy. However, solitary lung metastasis appeared 19 months after the initial TURBT. Multidisciplinary treatments including 25 courses of various multiagent chemotherapies, radiation therapy to the lung metastasis and surgical resection of a urethral recurrence were performed. Although a localized radiation pneumonitis was developed, the lung metastasis appeared to be controlled for 26 months after the radiation therapy to the lung. Bilateral ureteral and renal pelvic tumors appeared after the radiation therapy. Severe bleeding was occurred from renal pelvic tumors several times and she needed the hospital stay 2 times. Active bleeding stopped after the administration of chemotherapy each time. Although she died of occlusive jaundice due to the liver metastasis, she had been alive due to the multidisciplinary treatment for 67 months after lung metastasis appearance with relatively good performance status.
- Published
- 2017
- Full Text
- View/download PDF
25. [CLINICAL ANALYSIS ABOUT PERCUTANEOUS NEEDLE BIOPSY FOR RENAL MASSES].
- Author
-
Asakuma J, Isono M, Tsujita Y, Tasaki S, Kuroda K, Sato A, Horiguchi A, Seguchi K, Ito K, and Asano T
- Abstract
(Objective) We investigated the efficacy and safety of percutaneous renal mass biopsy retrospectively. (Methods) A retrospective review was performed of 44 patients (46 renal masses) who received ultrasound and/or computed tomography guided percutaneous biopsy of a solid renal mass between April 2004 and December 2012 in National Defense Medical College Hospital. (Results) The median renal mass size was 45 (range 15-140) mm with a median of 2 (1-5) cores taken. Thirteen masses were biopsied for differential diagnosis between RCC and other malignancies (or benign renal tumors), 11 were biopsied for differential diagnosis between RCC and renal pelvic urothelial carcinoma, 10 unresectable masses were biopsied to confirm the diagnosis pathologically before starting medication, and 12 small masses were biopsied before radio-frequency ablation. Of the initial 46 biopsies, 38 (82.6%) were diagnostic. The median lesion sizes in the diagnostic and nondiagnostic biopsy specimens were 45 (15-140) mm and 43 (17-128) mm. The median numbers of diagnostic and nondiagnostic cores were 2 (1-5) and 1.5 (1-4). These size and core number differences between the diagnostic and nondiagnostic biopsy specimens are not statistically significant. Of initial nondiagnostic 8 masses, 3 masses that were performed repeat biopsy resulted in determined diagnosis finally. There were mild postprocedural hematomas not requiring blood transfusion. There was no tumor dissemination after renal mass biopsy. (Conclusions) Percutaneous biopsy of renal masses is a safe procedure that provides diagnostic information.
- Published
- 2017
- Full Text
- View/download PDF
26. Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma.
- Author
-
Tasaki S, Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, Asano T, and Asakura H
- Abstract
The recent discovery and clinical development of targeted agents have expanded treatment options in metastatic renal cell carcinoma (RCC). However, metastatic RCC remains a lethal disease. Complete response is rare and treatment with targeted agents eventually fails in the majority of the patients. Therefore, there is a need for developing a prognostic tool and a novel therapeutic agent for RCC to improve the follow-up strategy after surgical treatment. Clinical data, including patient characteristics, serum fatty acid profile, clinicopathological parameters and clinical outcome, were obtained from 112 patients with RCC prior to surgical treatment. Preoperative fatty acid levels were grouped according to patient characteristics, such as performance status, body mass index or pathological parameters, and were analyzed using the Mann-Whitney U test. Cancer-specific survival in the high and low docosahexaenoic acid (DHA) level groups were compared using the Kaplan-Meier method. Cox proportional hazards models were applied to determine the independent prognostic factors associated with shortened cancer-specific survival. The serum DHA level in patients with metastasis was significantly lower compared with that in patients without metastasis (P=0.047). Low serum DHA level, presence of metastasis and cachexia were independent predictors of shortened cancer-specific survival in a multivariate Cox proportional hazard model (P=0.033, hazard ratio = 4.43). Patients with a serum DHA level below the median value exhibited significantly shorter cancer-specific survival compared with those with a higher serum DHA level (P=0.008). Thus, according to our results, the preoperative serum DHA level may be able to predict the surgical outcome of RCC. However, this finding requires validation by large-scale prospective studies.
- Published
- 2016
- Full Text
- View/download PDF
27. Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy.
- Author
-
Ito K, Asakuma J, Kuroda K, Tachi K, Sato A, Horiguchi A, Seguchi K, and Asano T
- Abstract
The prediction of extraurothelial recurrence (EUR) before radical nephroureterectomy (RNU) is difficult for patients with upper tract urothelial carcinoma. If EUR can be predicted preoperatively, it may be possible to determine the need for neoadjuvant chemotherapy or the surgical strategy. Our previous study identified preoperative risk factors for EUR in ureteral cancer, while the present study identified preoperative risk factors for EUR in renal pelvic cancer (RPC). The preoperative factors were reviewed in 71 N0M0 patients with RPC treated by RNU between 1999 and 2013. Preoperative clinical background data, laboratory test results, including inflammatory indices, lactate dehydrogenase (LDH), and estimated glomerular filtration rate, and radiological findings were subjected to multivariate analyses to identify independent predictive factors for EUR. The 3-year EUR-free survival (EURFS) rate was 81.9%, and univariate analysis showed that clinical T (cT) stage ≥3, white blood cell counts ≥7600/µl, neutrophil counts ≥4,500/µl, neutrophil-to-lymphocyte ratio ≥2.0, and LDH ≥210 IU/l were significantly associated with EURFS. Additionally, a cT stage ≥3 (P=0.0244) and LDH ≥210 IU/l (P=0.0322) were independent predictors for EUR. When patients were stratified into three groups according to the number of risk factors, the 3-year EURFS rates were 94.5, 76.3, and 33.3% for the low-, intermediate-, and high-risk patient groups, respectively. In conclusion, cT stage ≥3 and LDH ≥210 IU/l were preoperative predictive factors of EUR in patients with RPC. High-risk patients may be candidates for neoadjuvant chemotherapy and low-risk patients may be candidates for RNU without lymph node dissection.
- Published
- 2016
- Full Text
- View/download PDF
28. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
- Author
-
Kuroda K, Asakuma J, Asano T, Horiguchi A, Isono M, Tsujita Y, Sato A, Seguchi K, Ito K, and Asano T
- Subjects
- Adult, Aged, Carcinoma, Transitional Cell pathology, Carcinoma, Transitional Cell surgery, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Middle Aged, Neoplasm Recurrence, Local enzymology, Prognosis, Urologic Neoplasms pathology, Urologic Neoplasms surgery, Biomarkers, Tumor analysis, Carcinoma, Transitional Cell enzymology, Urinary Tract pathology, Urologic Neoplasms enzymology, Urothelium pathology, p21-Activated Kinases analysis
- Abstract
Objective: The p21-activated kinase serine/threonine kinases have been outlined as the main cytoskeletal remolding regulators. The same holds true for cell proliferation and motility. They additionally have a part in cellular invasion and carcinogenesis, but the effect of p21-activated kinase 1 expression on the progression of upper urinary tract urothelial carcinoma remains unclear. Therefore, we assessed the relation of p21-activated kinase 1 positivity level to clinicopathological features in patients with upper urinary tract urothelial carcinoma., Methods: Immunohistochemical staining was performed using formalin-fixed and paraffin-embedded specimens, which were all from 124 patients with upper urinary tract urothelial carcinoma. The determination of staining level was based on the intensity of the staining along with portion of cells stained. Correlation of p21-activated kinase 1 positivity with clinicopathological parameters, including disease-specific or extravesical-recurrence-free survival, was evaluated., Results: Statistically significant association was observed between moderate or more than moderate p21-activated kinase 1 positivity and higher tumor grade, pathological T stage, lymphovascular invasion, history of adjuvant chemotherapy and extravesical recurrence. Positivity for p21-activated kinase 1 had a significant association with shortened disease-specific survival in a multivariate analysis among clinicopathological parameters. Strongly positive p21-activated kinase 1 expression was also one of the independent factors for shortened extravesical-recurrence-free survival time in N0M0 upper urinary tract urothelial carcinoma patients in another multivariate analysis as well as histology and lymphovascular invasion (P = 0.0304, hazard ratio = 4.425)., Conclusions: We conclude that our findings can help us continue a careful follow-up for upper urinary tract urothelial carcinoma patients with high p21-activated kinase 1 expression in surgical specimens., (© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
29. Surgical removal of the solitary metastasis of renal cell carcinoma in the third ventricle using an interhemispheric transcallosal trans-choroidal approach.
- Author
-
Otani N, Wada K, Kumagai K, Takeuchi S, Nagatani K, Tomura S, Osada H, Asakuma J, and Mori K
- Abstract
We herein describe a case of a solitary metastasis of renal cell carcinoma (RCC) in the third ventricle, which was totally removed via an interhemispheric trans-callosal trans-choroidal approach. The histological examination revealed a solitary metastasis of RCC. The postoperative course was uneventful. A stereotactic cyber knife was additionally used for the tumor cavity. As of 2 years after surgery, the patient has been doing well without recurrence. This case highlights the urgent need for an early diagnosis and surgical treatment for solitary metastasis of RCC to the third ventricle due to its critical course.
- Published
- 2015
- Full Text
- View/download PDF
30. Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis.
- Author
-
Hamada S, Ito K, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi K, and Asano T
- Abstract
The prognosis of patients with renal cell carcinoma (RCC) and liver metastasis (LM) is poor. We evaluated the clinical characteristics, prognosis and prognostic factors of RCC patients with LM. A total of 25 patients who underwent radical or partial nephrectomy (Nx) for RCC between November, 1980 and April, 2013 at the National Defense Medical College, Tokorozawa, Saitama, Japan, with LM at initial presentation or following Nx, were included in this study. The association between prognosis following development of LM and clinicopathological parameters was analyzed. The Cox proportional hazards regression model was used to identify prognostic predictors. The median cancer-specific survival (CSS) following LM diagnosis was 10.6 months. The presence of sarcomatoid differentiation, Eastern Cooperative Oncology Group performance status (ECOG PS) ≥2, C-reactive protein ≥1.0 mg/dl, corrected calcium ≥10 mg/dl and presence of multiple organ metastases, were identified as CSS predictors. The multivariate analysis identified ECOG PS ≥2 as an independent CSS predictor. Nine patients survived for >20 months following LM diagnosis and 1 patient, who received treatment with tyrosine kinase inhibitors (TKIs) for LM, exhibited stable disease for 5 years. Nine patients underwent local LM treatment. Two patients, who underwent hepatic resection, survived for 55.1 and 22 months, respectively. In conclusion, RCC patients with LM may benefit from local LM treatment if they have a limited number of metastases in addition to LM and if their ECOG PS is satisfactory. Indeed, a proportion of RCC patients with LM benefit from TKI therapy. Furthermore, RCC patients with LM and ECOG PS ≥2 apparently have a poor prognosis, regardless of local or systemic therapies.
- Published
- 2015
- Full Text
- View/download PDF
31. Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma.
- Author
-
Ito K, Seguchi K, Shimazaki H, Takahashi E, Tasaki S, Kuroda K, Sato A, Asakuma J, Horiguchi A, and Asano T
- Abstract
Patients with pT1aN0M0 renal cell carcinoma (RCC) generally have good prognosis, and recurrence is rare. However, metastasis develops postoperatively in a small number of patients with pT1aN0M0 RCC. The present study was undertaken to identify predictors for recurrence in patients with pT1aN0M0 RCC. We reviewed the clinicopathological factors of 133 patients with pT1aN0M0 RCC who underwent radical or partial nephrectomy at the Department of Urology, National Defense Medical College (Saitama, Japan). Clinicopathological factors, including age, gender, tumor size, histological subtype, tumor grade, microvascular invasion, histological tumor necrosis, C-reactive protein levels and performance status were reviewed. These factors were compared between patients with and without postoperative recurrence. Recurrence-free survival (RFS) and cause-specific survival (CSS) rates were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed to determine independent factors predicting recurrence in patients with pT1aN0M0 RCC. The 5-year RFS and CSS rates were 97.2 and 99.1%, respectively. When clinicopathological factors were compared between patients with and without recurrence, tumor size (P=0.0390) and percentage of tumor necrosis (P<0.0001) were significantly different between groups. All patients with recurrence had primary lesions ≥3 cm. By univariate analysis, tumor size (P=0.0379) and the presence of tumor necrosis (P=0.0319) were significant predictors for recurrence; tumor necrosis was also an independent predictor for recurrence (P=0.0143). In patients with pT1b tumors ≤5 cm (recurrence rate, 16.8%; n=48), the percentage of tumor necrosis was significantly higher in patients with recurrence compared with those without (P=0.0261). This suggests that tumor necrosis may be an important predictor for recurrence in small RCCs. Although recurrence is rare in pT1a RCC, the presence of tumor necrosis may be an important predictor for recurrence. Particularly, patients presenting with pT1a RCC with histological tumor necrosis should undergo careful follow-up.
- Published
- 2015
- Full Text
- View/download PDF
32. Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy.
- Author
-
Ito K, Kuroda K, Asakuma J, Hamada S, Tachi K, Tasaki S, Sato A, Horiguchi A, Seguchi K, and Asano T
- Subjects
- Aged, Carcinoma, Transitional Cell diagnosis, Carcinoma, Transitional Cell secondary, Female, Follow-Up Studies, Humans, Incidence, Japan epidemiology, Lymph Node Excision, Lymphatic Metastasis, Male, Preoperative Period, Prognosis, Retrospective Studies, Risk Factors, Time Factors, Ureteral Neoplasms pathology, Carcinoma, Transitional Cell surgery, Neoplasm Recurrence, Local epidemiology, Nephrectomy methods, Risk Assessment, Ureter surgery, Ureteral Neoplasms surgery
- Abstract
Purpose: Recent studies have suggested that lymph node dissection may improve the prognosis in patients with upper tract urothelial carcinoma. Therefore, patients who will benefit from lymph node dissection need to be selected before surgery. Because patients who have extraurothelial recurrence theoretically include those whose prognoses are improved by lymph node dissection, we conducted this study to determine the preoperative predictors of extraurothelial recurrence in patients with ureteral cancer., Materials and Methods: Because it is not appropriate to categorize the preoperative radiologic findings of ureteral cancer and those of renal pelvic cancer using the same classification criteria, we focused on ureteral cancer. We reviewed preoperative factors in 70 patients with ureteral cancer treated with radical nephroureterectomy. Laboratory tests including inflammatory indices, tumor markers and estimated glomerular filtration rate, along with radiologic findings, were evaluated. Multivariate analyses were performed to determine independent factors predicting extraurothelial recurrence in patients with ureteral cancer., Results: Positive cytology, cT stage 3 or greater, length of ureteral cancer 3 cm or greater and estimated glomerular filtration rate less than 60 ml/minute/1.73 m2 were independent predictors of extraurothelial recurrence on multivariate analysis. When patients were stratified into 3 groups according to the number of risk factors, the 3-year extraurothelial recurrence-free survival rates were 95.2% in the low risk group, 75.8% in the intermediate risk group and 25.1% in the high risk group., Conclusions: Positive cytology, cT stage 3 or greater, length of ureteral cancer 3 cm or greater and estimated glomerular filtration rate less than 60 ml/minute/1.73 m2 were preoperative predictive factors of extraurothelial recurrence in patients with ureteral cancer and lymph node dissection may be omitted for low risk patients., (Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
33. Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma.
- Author
-
Hamada S, Horiguchi A, Asano T, Kuroda K, Asakuma J, Ito K, Asano T, Miyai K, and Iwaya K
- Subjects
- Adult, Aged, Carcinoma, Transitional Cell surgery, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Urologic Neoplasms surgery, Biomarkers, Tumor analysis, Carcinoma, Transitional Cell enzymology, Carcinoma, Transitional Cell pathology, Fatty Acid Synthase, Type I analysis, Neoplasm Recurrence, Local enzymology, Urologic Neoplasms enzymology, Urologic Neoplasms pathology
- Abstract
Objective: Fatty acid synthase has been shown to be highly expressed in various types of cancers with increased tumour aggressiveness. In this study we examined the level of fatty acid synthase expression in surgically resected upper urinary tract urothelial carcinoma specimens and evaluated the relations between fatty acid synthase expression and the patients' pathological features and clinical outcomes., Methods: Sections of paraffin-embedded tumour specimens from 113 patients who underwent surgical treatment for upper urinary tract urothelial carcinoma were immunostained with a polyclonal fatty acid synthase antibody, and a tumour was considered to have high fatty acid synthase expression if >50% of the cancer cells stained with moderate-to-strong intensity. Associations between fatty acid synthase expression and the patients' pathological parameters and survival were analyzed statistically., Results: During the follow-up time (median: 46.8 months), 61 patients (54.0%) had recurrence and 17 (15.0%) died of upper urinary tract urothelial carcinoma. High fatty acid synthase expression was significantly associated with high tumour grade (P = 0.0273). Patients with high fatty acid synthase expression had significantly worse recurrence-free survival and extravesical-recurrence-free survival than those with low fatty acid synthase expression (P = 0.0171, P = 0.0228, respectively). In multivariate analysis, high fatty acid synthase expression was an independent predictor of shortened recurrence-free survival (P = 0.0220, hazard ratio (HR) = 1.970)., Conclusions: Fatty acid synthase expression in upper urinary tract urothelial carcinoma is an independent predictor for tumour recurrence. Patients with high fatty acid synthase expression in upper urinary tract urothelial carcinoma should be followed carefully and adjuvant therapy for them should be considered.
- Published
- 2014
- Full Text
- View/download PDF
34. [The diagnostic value of pre-biopsy magnetic resonance imaging for precise detection of clinically localized prostate cancer compared to post-biopsy setting].
- Author
-
Takahashi M, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Seguchi K, Hayakawa M, Ito K, Asano T, Tamura C, and Shinmoto H
- Subjects
- Artifacts, Biopsy, Hemorrhage etiology, Humans, Male, Postoperative Period, Predictive Value of Tests, Prostatectomy, Sensitivity and Specificity, Magnetic Resonance Imaging, Prostatic Neoplasms diagnosis
- Abstract
A total of 136 patients who underwent radical prostatectomy following histological diagnosis of prostate cancer by transrectal biopsy and 3-Tesla magnetic resonance imaging (MRI) were evaluated. MRI was performed on 26 patients before prostate biopsy (pre-biopsy group) and on 110 patients after prostate biopsy (post-biopsy group). We defined the largest tumor focus in a radical prostatectomy specimen as the index cancer. We compared the accuracy of MRI in detecting and localizing the index cancer in the groups. The sensitivity of detecting the index cancer by MRI was significantly (p = 0.012) higher in the pre-biopsy group (96.2%) than in the post-biopsy group (77. 3%). The negative predictive value of extracapsular invasion was 84.6% in the pre-biopsy group and 80.7% in the post-biopsy group. The average interval between biopsy and MRI was 42.8 days. Artifacts due to post-biopsy hemorrhage were observed in 32 (29.1%) of the patients in the post-biopsy group. The sensitivity of detecting the index cancer by MRI was significantly (p = 0.022) higher in 78 patients without artifacts due to hemorrhage (83.3%) than in the 32 patients with artifacts due to hemorrhage (62.5%). Even if MRI is delayed until after prostate biopsy,the artifact due to hemorrhage markedly interferes with the accuracy of MRI. Although pre-biopsy MRI is more accurate than post-biopsy MRI,there are some problems to be solved,such as cost effectiveness and the detectability of low-malignant and small cancers.
- Published
- 2013
35. Modified posterior musculofascial plate reconstruction decreases the posterior vesicourethral angle and improves urinary continence recovery in patients undergoing laparoscopic radical prostatectomy.
- Author
-
Ito K, Kenji S, Yoshii H, Hamada S, Asakuma J, Tasaki S, Kuroda K, Sato A, Horiguchi A, and Asano T
- Abstract
The aim of this study was to evaluate the efficacy of our modified posterior musculofascial plate reconstruction (PMPR) procedure in laparoscopic radical prostatectomy (LRP). Prior to 2010, four operative procedures were used to expedite continence recovery: preserving the fascia covering the levator ani muscle, preserving the bladder neck, securing a functional urethral length by using a lateral-view dissection technique and suspending the vesicourethral anastomosis from the puboprostatic ligaments. Since February, 2010, a running suture between Denonvilliers' fascia (DF) and the median fibrous raphe (MFR, the fibrous tissue that lies immediately underneath the urethra) has also been used. In vesicourethral anastomosis, a double-armed running suture was performed. At the beginning of the anastomosis, the first stitches (at 1 and 11 o'clock positions on the bladder neck) were placed 1-2 cm dorsocephalad to the bladder neck (first through the seromuscular layer and then through the full thickness of the bladder neck). At the 5 and 7 o'clock positions of the urethra, the stitches were placed through the urethral mucosa as well as the the reconstructed musculofascial plate. The bladder shape was evaluated by postoperative cystography and the clinical results were compared between patients undergoing LRP without PMPR (group A) and those undergoing LRP with PMPR (group B). The cystograms demonstrated that the PMPR significantly shortened the vertical length of the bladder and significantly decreased the posterior vesicourethral angle. At 1, 3 and 6 months after LRP, the number of daily used pads was significantly lower in group B compared to that in group A and the time to achieve a pad-free status was significantly shorter in group B. Our modified PMPR procedure significantly improved the recovery of urinary continence following LRP and this improvement may be due in part to changes of the bladder shape.
- Published
- 2013
- Full Text
- View/download PDF
36. [Causes and salvage of failed urethroplasties for traumatic urethral injury].
- Author
-
Horiguchi A, Azuma R, Tasaki S, Hamada S, Kuroda K, Sato A, Asakuma J, Seguchi K, Hayakawa M, Ito K, and Asano T
- Subjects
- Adolescent, Humans, Male, Middle Aged, Reoperation, Salvage Therapy, Treatment Outcome, Urethral Stricture etiology, Plastic Surgery Procedures methods, Urethra injuries, Urethra surgery
- Abstract
Objectives: Salvage urethroplasty after failed repair of traumatic urethral injury is a urological challenge, and we herein describe our experience with it., Methods: From October 2010 to January 2012, five patients underwent salvage repair of failed urethroplasties for traumatic urethral injuries: three bulbar straddle injuries and two pelvic fracture urethral injuries. One of the three failed urethroplasties for bulbar straddle injuries was a stricture excision and primary anastomosis, and its failure was due to periurethral abscess formation. Another was an augmented anastomotic urethroplasty using buccal mucosa, and its failure was due to periurethral abscess formation. The third was a tube graft urethroplasty using buccal mucosa, and its failure was due to a stricture at the anastomotic site. Two failed urethroplasties for pelvic fracture urethral injuries were perineal anastomotic repairs combined with corporal separation and inferior pubectomy, and the failures of both were due to ischemic bulbar necrosis. The urethral gap lengths estimated from urethrograms ranged from 12 to 45 mm (mean = 26 mm)., Results: Urethroplasties in all patients with bulbar straddle injuries were salvaged by stricture excision and primary anastomosis with corporal separation, and urethroplasties in both patients with pelvic fracture urethral injuries were salvaged by abdominal transpubic perineal urethroplasty. Although the patients who underwent transpubic urethroplasty had transient pelvic girdle pain, no severe complications were observed. All patients were for 10 to 25 months postoperatively (mean = 16 months) able to void satisfactorily without additional treatment., Conclusions: Failed urethroplasties for traumatic urethral injuries can be salvaged with a second reconstruction surgery. The procedure of choice for this salvage is anastomotic urethroplasty with techniques for tension-free anastomosis.
- Published
- 2013
- Full Text
- View/download PDF
37. [Evaluation of clinical results in patients undergoing laparoscopic nephroureterectomy].
- Author
-
Hamada S, Ito K, Takahashi M, Isono M, Tasaki S, Yoshii H, Kuroda K, Satou A, Asakuma J, Seguchi K, Horiguchi A, Sumitomo M, and Asano T
- Subjects
- Adult, Aged, Aged, 80 and over, Blood Loss, Surgical, Female, Humans, Male, Middle Aged, Operative Time, Postoperative Complications, Treatment Outcome, Urologic Neoplasms surgery, Laparoscopy, Nephrectomy methods, Ureter surgery
- Abstract
We evaluated the efficacy of laparoscopic radical nephroureterectomy (LNUx) by comparing the clinical results in 55 patients undergoing LNUx at the National Defense Medical College since 2001 with those in patients undergoing open radical nephroureterectomy (ONUx) there over the same period. LNUx was performed successfully in 54 of the patients, but one patient required conversion to ONUx. The mean operating time for LNUx was not significantly different from that for ONUx, and the mean estimated blood loss during LNUx was significantly lower than that during ONUx. Major complications occurring early in our laparoscopic series of cases were injury of the duodenum and bleeding from the inferior vena cava. Oncological outcomes were compared between LNUx (n=50) and ONUx (n=50) in patients with pathologically-confirmed urothelial carcinoma. The pT stage, histological grade, percentage of lymph node dissection and percentage of high grade hydronephrosis did not differ significantly between the two groups. Because the intravesical recurrence-free survival rates, extravesical recurrence-free survival rates, and disease specific survival rates were also similar in the two groups, we concluded that LNUx is an appropriate treatment for upper urinary tract urothelial carcinoma.
- Published
- 2013
38. [The efficacy of direct vision internal urethrotomy for male urethral stricture].
- Author
-
Isono M, Horiguchi A, Tasaki S, Kuroda K, Sato A, Asakuma J, Seguchi K, Ito K, Hayakawa M, and Asano T
- Subjects
- Adult, Aged, Humans, Male, Middle Aged, Urologic Surgical Procedures, Male methods, Urethra surgery, Urethral Stricture surgery
- Abstract
Objective: Direct vision internal urethrotomy (DVIU) has been considered to be a low invasive and widely used therapeutic modality for male urethral stricture. However, its efficacy is still controversial. We herein evaluated the efficacy of DVIU for male urethral stricture., Patients and Methods: Nineteen patients 27 to 78 years old (median age = 59) underwent DVIU for urethral strictures at our hospital were included in this study. Strictures were at bulbar urethra in 17 patients, membranous urethra in 1 patient, and pendulous urethra in 1 patient. The stricture lengths estimated on retrograde urethrography were less than 1 cm in 13 patients, 1-2 cm in 2 patients, and more than 2 cm in 4 patients. The etiology of stricture was straddle injury in 7 patients, post transurethral surgery in 7 patients, pelvic fracture in 1 patient, and unknown in 4 patients. The operation was done by cold knife incision using guidewire. The duration of postoperative urethral catheterization was 5 to 35 days (mean 12.8 days). Follow up duration ranged from 1 month to 139 months (mean 48.2 months). The definition of postoperative re-stricture was the confirmation of re-stricture on retrograde urethrography or deterioration of symptom., Results: While no severe complication was observed, postoperative re-stricture was seen in 13 patients. Stricture-free rates at 3 months, 6 months, and 5 years after the first DVIU were 44.4%, 38.1%, 20.3% respectively. Although second DVIU was done for 7 patients with re-stricture, six patients resulted in failure. Stricture-free rates at 3 months, 6 months, and 5 years after the second DVIU were 42.2%, 28.6%, 14.3% respectively. Though the third DVIU was done for two of them, they were unable to void just immediately after the removal of urethral catheters. Stricture-free rate in stricture less than 1 cm was higher than that in 1 cm or longer, though it did not reach significant difference (p = 0.1813)., Conclusion: The efficacy of DVIU is lesser than we expected. DVIU seems to be excessively applied to male urethral strictures and should not be performed for long and recurrent urethral stricture.
- Published
- 2012
- Full Text
- View/download PDF
39. Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer.
- Author
-
Kuroda K, Horiguchi A, Asano T, Tasaki S, Yoshii H, Sato A, Asakuma J, Ito K, Seguchi K, Sumitomo M, and Asano T
- Subjects
- Aged, Antibodies, Monoclonal, Murine-Derived, Biopsy, Disease-Free Survival, Endothelium, Lymphatic immunology, Humans, Immunohistochemistry, Japan, Kaplan-Meier Estimate, Logistic Models, Lymphatic Vessels immunology, Male, Middle Aged, Multivariate Analysis, Neoplasm Invasiveness, Predictive Value of Tests, Proportional Hazards Models, Prostatic Neoplasms immunology, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Up-Regulation, Endothelium, Lymphatic pathology, Lymphatic Vessels pathology, Prostate-Specific Antigen blood, Prostatectomy adverse effects, Prostatectomy mortality, Prostatic Neoplasms surgery
- Abstract
Introduction: Lymphatic invasion has been associated with biochemical recurrence (BCR), and many patients with postoperative elevation of prostate-specific antigen (PSA) develop distant metastases within several years. We previously found peritumoral lymphatic vessel density (PTLD) in biopsy cores to be an independent predictor of lymphatic invasion in radical prostatectomy specimens, so we speculate that PTLD parameters in biopsy specimens could also be independent predictors of BCR after surgery., Patients and Methods: We obtained positive biopsy cores from 110 patients who underwent radical prostatectomy at our institution. Biopsy cores were immunostained with the D2-40 monoclonal antibody, which specifically and selectively detects lymphatic endothelium. We evaluated differences between the BCR-free survival rates and used univariate and multivariate analyses to detect independent predictors of BCR., Results: The results of a Cox proportional hazards model showed that lymphatic invasion in prostatectomy specimens was one of the independent postoperative prognostic factors for BCR (p = 0.0338). An additional model showed that one PTLD parameter, maximal PTLD, was among the independent preoperative predictors of lower BCR-free survival rates (p = 0.0200)., Conclusions: Information about PTLD in prostate biopsy specimens could be helpful for selecting patients as radical prostatectomy candidates, and patients with high PTLD values should be carefully monitored after surgery., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF
40. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
- Author
-
Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, and Asano T
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma mortality, Carcinoma secondary, Chemotherapy, Adjuvant, Disease-Free Survival, Female, Humans, Japan, Logistic Models, Lymphatic Vessels pathology, Male, Middle Aged, Multivariate Analysis, Neoplasm Recurrence, Local, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, Risk Assessment, Risk Factors, Survival Analysis, Time Factors, Treatment Outcome, Tumor Burden, Ureter pathology, Urologic Neoplasms mortality, Urologic Neoplasms pathology, Urothelium pathology, Carcinoma surgery, Nephrectomy adverse effects, Nephrectomy mortality, Ureter surgery, Urologic Neoplasms surgery, Urothelium surgery
- Abstract
Introduction: The purpose of this study was to evaluate prognostic factors for patients with upper urinary tract urothelial carcinoma (UUT-UC) after nephroureterectomy and to seek a better way of finding more favorable clinical results for these patients., Patients and Methods: We retrospectively reviewed the medical records of 121 UUT-UC patients who underwent a nephroureterectomy at our institution, and analyzed the prognostic significance of various clinicopathological parameters for progression-free and disease-specific survival rates by using univariate and multivariate analysis., Results: A Cox proportional hazards model showed that extravesical tumor recurrence after surgery was an independent prognostic factor for disease-specific survival (p < 0.0001). An additional model showed that lymphovascular invasion (LVI) was one of the independent predictors of lower extravesical-recurrence-free survival rates (p = 0.0004). Our final finding was that pathological tumor stage and positive surgical margin were significantly associated with the presence of LVI (p < 0.0001 and p = 0.0029, respectively)., Conclusions: We conclude that there is a high possibility of LVI in patients with large tumors. Our findings should be helpful in terms of determining whether or not to perform neoadjuvant chemotherapy for patients with large tumors, given the fact that we frequently find a severe reduction in renal function after nephroureterectomy., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF
41. Impact of postoperative C-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma.
- Author
-
Ito K, Yoshii H, Sato A, Kuroda K, Asakuma J, Horiguchi A, Sumitomo M, and Asano T
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Renal Cell pathology, Carcinoma, Renal Cell surgery, Humans, Kidney Neoplasms pathology, Kidney Neoplasms surgery, Middle Aged, Neoplasm Recurrence, Local epidemiology, Neoplasm Staging, Postoperative Period, Predictive Value of Tests, Prognosis, Retrospective Studies, Survival Rate, C-Reactive Protein analysis, Carcinoma, Renal Cell blood, Carcinoma, Renal Cell mortality, Kidney Neoplasms blood, Kidney Neoplasms mortality, Neoplasm Recurrence, Local blood, Neoplasm Recurrence, Local mortality
- Abstract
Purpose: Preoperative C-reactive protein is a strong predictor of recurrence and prognosis in patients with renal cell carcinoma while postoperative C-reactive protein reportedly predicts survival in patients with metastatic renal cell carcinoma. We evaluated the impact of postoperative C-reactive protein on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma., Materials and Methods: We defined increased preoperative C-reactive protein as 1 mg/dl or greater and postoperative C-reactive protein normalization as at least 1 postoperative measurement of less than 0.3 mg/dl. We reviewed the records of 263 patients with N0M0 clear cell renal cell carcinoma who underwent nephrectomy, and in whom preoperative and postoperative C-reactive protein values were available. We used multivariate analysis to identify independent factors predicting recurrence and prognosis. We also evaluated C-reactive protein at recurrence and its impact on survival., Results: Increased preoperative C-reactive protein and nonnormalization of postoperative C-reactive protein were associated with worse clinicopathological factors. Postoperative C-reactive protein nonnormalization, increased preoperative C-reactive protein, microvascular invasion and histological tumor necrosis were independent predictors for recurrence. Risk stratification using these factors effectively predicted the possibility of recurrence. Anemia, thrombocytosis and postoperative C-reactive protein nonnormalization were independent predictors of overall survival. Postoperative followup revealed recurrence in 50 patients. The 3-year survival rate in patients with C-reactive protein 0.3 mg/dl or greater at recurrence was significantly lower than that in patients with less than 0.3 mg/dl at recurrence (47.3% vs 81.6%)., Conclusions: Nonnormalization of postoperative C-reactive protein is a strong predictor of recurrence and prognosis. Patients with C-reactive protein 0.3 mg/dl or greater at recurrence might not survive as long as those with C-reactive protein less than 0.3 mg/dl at recurrence., (Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
42. [Clinical experience of 52 patients undergoing laparoscopic radical prostatectomy].
- Author
-
Ito K, Yoshii H, Miyajima A, Kanbara T, Tsujita Y, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi T, Sumitomo M, Hayakawa M, and Asano T
- Subjects
- Humans, Intraoperative Complications, Male, Middle Aged, Treatment Outcome, Laparoscopy, Prostatectomy methods
- Abstract
Perioperative results and oncological and functional results were evaluated for 52 patients who underwent laparoscopic radical prostatectomy (LRP). Median operative time was 341 minutes and median blood loss was 828 ml. The intraoperative complications were hemorrhage exceeding 3,000 ml (five cases), ureteral injury (two cases), and rectal injury (one case). The median day of catheter removal was postoperative day 7. Postoperative complications were temporal arrhythmia, mild hydronephrosis, port site hernia, urethral stricture, and a giant lymphocele. When surgical results were compared between the firsthalf cases and second-half cases who were operated on by a single surgeon, median operative time and intraoperative hemorrhage did not differ significantly between the two halves but the day of catheter removal after LRP was significantly earlier for the second-half group. The pathological stage was pT3 in 41.2% of the patients and the negative surgical margin rate was 62.7%. The 3-year PSA-failure-free survival rate was 64. 1%. Pad-free status (0-1 pad/day) was achieved in 84.4% of the patients. Erectile function was preserved in 58.3% of patients undergoing nerve-sparing LRP. Although the complication rate and the quality of operative procedures gradually improved, efforts to improve the oncological and functional outcomes of LRP must continue.
- Published
- 2011
43. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
- Author
-
Kuroda K, Horiguchi A, Asano T, Ito K, Asakuma J, Sato A, Yoshii H, Hayakawa M, Sumitomo M, and Asano T
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Renal Cell mortality, Carcinoma, Renal Cell secondary, Carcinoma, Renal Cell surgery, Disease-Free Survival, Endoplasmic Reticulum Chaperone BiP, Female, Humans, Immunohistochemistry, Japan, Kaplan-Meier Estimate, Kidney Neoplasms mortality, Kidney Neoplasms pathology, Kidney Neoplasms surgery, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Grading, Neoplasm Invasiveness, Paraffin Embedding, Prognosis, Proportional Hazards Models, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Up-Regulation, Biomarkers, Tumor analysis, Carcinoma, Renal Cell chemistry, Heat-Shock Proteins analysis, Kidney Neoplasms chemistry
- Abstract
Introduction: Glucose-regulated protein 78 (GRP78), a chaperone for newly formed proteins during folding and glycosylation, is associated with resistance to apoptosis in some forms of cancer. We assessed GRP78 expression and its correlation with clinicopathological parameters and survival., Patients and Methods: Immunohistochemistry was performed using formalin-fixed, paraffin-embedded specimens: 128 primary renal cell carcinoma (RCC) specimens (120 conventional and 8 other cell types) and 9 metastatic specimens. GRP78 positivity was determined based on intensity of staining and percentage of cells stained. Correlation of GRP78 positivity with clinicopathological parameters including patients' survival was evaluated., Results: A statistically significant association was found between GRP78 positivity and higher tumor grade (G3; p <0.0001), advanced T stage (≥pT3; p = 0.0002), lymphovascular invasion (positive; p <0.0001), regional nodal involvement (≥N1; p = 0.0086), and distant metastases at presentation (M1; p = 0.001). Positivity of GRP78 expression was significantly associated with shorter disease-specific survival and shorter progression-free survival. Cox proportional hazard model showed that strong GRP78 positivity was an independent predictor of shortened progression-free survival in N0M0 RCC patients., Conclusions: There was a significant relationship between GRP78 expression levels and aggressiveness of RCC. Increased expression of GRP78 might be a useful parameter to predict shortened survival in patients with RCC., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
44. Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
- Author
-
Sumitomo M, Asakuma J, Sato A, Ito K, Nagakura K, and Asano T
- Subjects
- Adult, Aged, Aged, 80 and over, Cohort Studies, Combined Modality Therapy, Disease-Free Survival, Humans, Japan, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Multivariate Analysis, Neoplasm Recurrence, Local mortality, Neoplasm Staging, Prognosis, Prostate-Specific Antigen blood, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology, Retrospective Studies, Risk Assessment, Statistics, Nonparametric, Survival Analysis, Time Factors, Transurethral Resection of Prostate adverse effects, Treatment Outcome, Ultrasound, High-Intensity Focused, Transrectal adverse effects, Urethral Stricture etiology, Urethral Stricture physiopathology, Urination Disorders etiology, Urination Disorders physiopathology, Neoadjuvant Therapy methods, Neoplasm Recurrence, Local pathology, Prostatic Neoplasms therapy, Transurethral Resection of Prostate methods, Ultrasound, High-Intensity Focused, Transrectal methods
- Abstract
Objectives: To evaluate the long-term outcomes of transurethral resection of the prostate (TURP) immediately after high-intensity focused ultrasound (HIFU) treatment for prostate cancer (CaP)., Methods: The present retrospective study included 65 CaP patients who underwent HIFU alone and 64 patients who underwent TURP immediately after HIFU. HIFU treatment was carried out using a Sonablate-500 HIFU device (Focus Surgery, Indianapolis, IN, USA). International Prostate Symptom Score (IPSS) and the occurrence of urinary complications, such as urethral stricture during follow-up, were statistically compared between groups., Results: Clinical stage tended to be lower for the HIFU+TURP group (P=0.0311), but none of the preoperative parameters differed significantly between groups. Both catheterization time (P<0.0001) and post-treatment IPSS (P<0.0001) at 6, 12, and 24months after treatment differed significantly between groups. Urethral strictures were noted in 16 (24.6%) of the HIFU-only patients and seven (10.9%) of the HIFU+TURP patients. Bladder neck contracture was noted in 11 (68.8%) of the patients with urethral stricture in the HIFU-only group, but in just two (28.6%) of the patients with urethral stricture in the HIFU+TURP group. Multiple logistic regression analyses showed that TURP resection volume (P=0.0118) was a strong factor for the prevention of urethral stricture., Conclusions: Our results suggest that combining HIFU with an immediately following TURP improves post-treatment urinary status without causing additional morbidity., (© 2010 The Japanese Urological Association.)
- Published
- 2010
- Full Text
- View/download PDF
45. Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.
- Author
-
Sumitomo M, Asakuma J, Yoshii H, Sato A, Horiguchi A, Ito K, Nagakura K, and Asano T
- Subjects
- Adult, Aged, Aged, 80 and over, Humans, Male, Middle Aged, Prognosis, Prostatic Neoplasms complications, Rectum pathology, Adipose Tissue pathology, Neoplasm Recurrence, Local epidemiology, Obesity complications, Prostatic Neoplasms epidemiology, Prostatic Neoplasms surgery, Ultrasound, High-Intensity Focused, Transrectal
- Abstract
Objective: To evaluate if and why obesity affects the clinical outcome in patients undergoing high-intensity focused ultrasound (HIFU) treatment for prostate cancer (CaP)., Methods: 115 patients who underwent HIFU treatment for localized CaP were categorized as obese, overweight or normal according to body mass index (BMI). The thickness of the anterior perirectal fat tissue (APFT) was measured by transrectal ultrasonography. Treatment was considered to have failed in the case of biochemical failure according to the Phoenix definition, positive follow-up biopsy or initiation of salvage therapy. Cox proportional hazards analyses were used to identify possible predictors for disease free survival (DFS), and an experimental fat tissue model was made to evaluate the ablation effect at the target tissue., Results: According to the classification by the Western Pacific Regional Office of WHO, 43 patients were of normal weight, 24 were overweight and 48 were obese. The BMI groups did not differ in Gleason score, prostate-specific antigen level at diagnosis or clinical stage. There were, however, significant correlations between BMI and prostate-specific antigen nadir (P < 0.001), and BMI and APFT thickness (P < 0.01). Multivariate analyses showed that BMI fails to be an independent predictor of DFS when APFT (P < 0.0001) is included as a variable., Conclusions: Our results suggest that APFT thickness, for which obesity could be a useful surrogate, might represent the causative factor for poor clinical outcome after transrectal HIFU treatment for CaP.
- Published
- 2010
- Full Text
- View/download PDF
46. [A case of labial adhesion in a reproductive woman].
- Author
-
Tsujita Y, Asakuma J, Kanbara T, Yoshii T, Azuma R, Sumitomo M, and Asano T
- Subjects
- Female, Humans, Tissue Adhesions, Urination Disorders etiology, Vulva surgery, Young Adult, Vulva pathology
- Abstract
A 21-year-old woman was admitted to our hospital with a complaint of voiding-difficulty and urinary retention. On examination, the labia was found to be extensively fused with a pinhole opening in the center of adhesion from which urine discharged. The fusion was separated surginally under the diagnosis of labial adhesion. Labial adhesions generally occur in children or post-menopausal women, but are extremely rare in reproductive women. This is the sixth case of labial adhesion in a reproductive woman reported in Japan.
- Published
- 2010
47. [Urothelial carcinoma clear cell variant of the urinary bladder : a case report].
- Author
-
Isono M, Asano T, Shirotake S, Tasaki S, Asakuma J, Satoh M, Kimura F, Dai Y, and Aida S
- Subjects
- Aged, Carcinoma surgery, Female, Humans, Urinary Bladder Neoplasms surgery, Carcinoma pathology, Urinary Bladder Neoplasms pathology
- Abstract
A 69-year-old woman who had been treated with hemodialysis for 16 months for chronic renal failure presented with a chief complaint of gross hematuria in March 2007. Cystoscopic examination revealed a non-papillary, pedunculated tumor located in the right wall of the urinary bladder. A transurethral resection of the bladder tumor (TURBT) was performed in September 2007. The pathological diagnosis was urothelial carcinoma clear cell variant. The patient is now apparently free of disease 20 months after TURBT. Urothelial carcinoma clear cell variant of the urinary bladder is a rare primary tumor, and this is the fourth case of urothelial carcinoma clear cell variant of the bladder to be reported.
- Published
- 2010
48. [Oral mucosa graft urethroplasty for complicated urethral strictures].
- Author
-
Horiguchi A, Sumitomo M, Kanbara T, Tsujita Y, Yoshii T, Yoshii H, Satoh A, Asakuma J, Ito K, Hayakawa M, and Asano T
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Treatment Outcome, Mouth Mucosa transplantation, Plastic Surgery Procedures methods, Urethra surgery, Urethral Stricture surgery, Urologic Surgical Procedures methods
- Abstract
Objective: We evaluated the efficacy and outcome of one-stage oral mucosa graft urethroplasty, which is currently the procedure of choice for treating lengthy and complicated urethral strictures not amenable to excision and primary end-to-end anastomosis., Patients and Methods: Seven patients 33 to 74 years old (mean age = 53.7) underwent one-stage oral mucosa graft urethroplasty for a stricture in either the bulbar urethra (four patients), penile urethra (two patients), or pan-anterior urethra (one patient). Three of the strictures were due to trauma, one was due to inflammation, and one was due to a failed hypospadia repair. The other two were iatrogenic. All patients had previously undergone either internal urethrotomy or repeated urethral dilation. Three patients received a tube graft, three received a ventral onlay, and one received a dorsal onlay. A free graft of oral mucosa was harvested from the inside of each patient's left cheek, and if necessary to obtain a sufficient length, the harvest was extended to include mucosa from the lower lip and the right cheek. The graft lengths ranged from 2.5 to 12 cm (mean = 4.6 cm). A urethral catheter was left in place for 3 weeks postoperatively., Results: While no severe complications at the donor site were observed during follow-up periods ranging from 3 to 55 months (mean = 14 months), two patients who had received a tube graft developed distal anastomotic ring strictures that were managed by internal urethrotomy. The other five required no postoperative urological procedure even though one who had received a ventral onlay developed a penoscrotal fistula., Conclusion: Oral mucosa is an ideal urethral graft, and oral mucosa graft urethroplasty is an effective procedure for repairing complicated urethral strictures involving long portions of the urethra.
- Published
- 2010
- Full Text
- View/download PDF
49. [Adrenal metastasis of lung adenocarcinoma with unusual sites of lymph node metastasis and concomitant renal cell carcinoma: a case report].
- Author
-
Otsuki H, Ito K, Kosaka T, Mikami H, Yoshii H, Asakuma J, Kaji T, Asano T, and Hayakawa M
- Subjects
- Adenocarcinoma diagnostic imaging, Adrenal Gland Neoplasms surgery, Adrenalectomy, Carcinoma, Renal Cell surgery, Humans, Kidney Neoplasms surgery, Lung Neoplasms diagnostic imaging, Lymph Node Excision, Male, Middle Aged, Nephrectomy, Tomography, X-Ray Computed, Adenocarcinoma pathology, Adenocarcinoma secondary, Adrenal Gland Neoplasms secondary, Carcinoma, Renal Cell complications, Kidney Neoplasms complications, Lung Neoplasms pathology, Lymphatic Metastasis pathology, Neoplasms, Multiple Primary
- Abstract
A 58-year-old male presented to a clinic with general weakness. Right adrenal tumor was found by computed tomography and he was referred to our hospital. Imaging studies revealed right adrenal tumor (8 cm) with marked swelling of surrounding lymph nodes and synchronous left renal tumor (2 cm) that was weakly enhanced by contrast media. Needle biopsy of the left kidney proved to be clear cell type renal cell carcinoma (RCC) and the preoperative diagnosis was left RCC and right primary adrenal cancer with lymph node metastasis. We performed right adrenalectomy, lymph node dissection and left radical nephrectomy. Pathological findings of right adrenal tumor and lymph nodes were both metastatic adenocarcinoma, which was not consistent with RCC or adrenal-derived carcinoma. Then, we extensively reviewed preoperative radiological examinations and found a small lesion in the left upper lung. This lesion was attached to the mediastinal shadow and there was no obvious lymph node swelling around this lesion. According to pathological findings and an elevation of carcinoembryogenic antigen, the adrenal lesion was diagnosed as adrenal metastasis of lung adenocarcinoma.
- Published
- 2007
50. Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.
- Author
-
Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, and Hayakawa M
- Subjects
- Adult, Aged, Body Mass Index, Carcinoma, Renal Cell surgery, Disease-Free Survival, Female, Humans, Kidney Neoplasms surgery, Male, Middle Aged, Neoplasm Invasiveness, Receptors, Leptin, Treatment Outcome, Carcinoma, Renal Cell metabolism, Carcinoma, Renal Cell pathology, Kidney Neoplasms metabolism, Kidney Neoplasms pathology, Leptin blood, Receptors, Cell Surface metabolism
- Abstract
Purpose: Leptin, an adipocyte derived cytokine that is closely associated with obesity, was recently shown to be involved in carcinogenesis and cancer progression. Because obesity is a significant risk factor for renal cell carcinoma, we investigated the link between leptin and the development of renal cell carcinoma., Materials and Methods: Associations between preoperative serum leptin levels and leptin receptor expression in tumor specimens and various clinicopathological parameters were analyzed in 57 patients with renal cell carcinoma., Results: Serum leptin levels were 1.2 to 16.2 ng/ml (mean 4.5). Of 57 tumors 22 (38.6%) demonstrated high leptin receptor expression. Serum leptin levels were significantly higher in patients with vs without tumor specimen venous invasion (p = 0.030) and higher in patients with high vs low leptin receptor expression (p = 0.019). There were significant associations between high leptin receptor expression and the presence of venous invasion (p = 0.013), histological type (p = 0.0076) and regional lymph node metastasis (p = 0.047). Of 42 patients with N0M0 disease those with serum leptin 5.0 ng/ml or more had significantly shorter progression-free survival than patients with lower levels (p = 0.0043). Multivariate Cox proportional hazards model analysis demonstrated that higher serum leptin was an independent predictor of progression-free survival (p = 0.0406)., Conclusions: Leptin and leptin receptor could have a key role in the invasion of renal cell carcinoma and they could be valuable predictors of progression.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.